Kissei Pharmaceutical Co., Ltd.

TSE:4547.T

3495 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 11,16113,68016,5077,4764,6307,12111,69710,11611,13610,46613,4007,9928,0746,3326,6163,3584,4713,1733,5877,980
Depreciation & Amortization 4,2544,1093,7303,1482,5622,6072,4922,3702,3432,2032,1902,3902,6352,8093,2333,7093,8623,2283,1383,011
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital -9,288-5,500116-7,6869,296561-2,128-1,848-4,773597121,432-3,742-2,1017974,192-694-726262-31
Accounts Receivables -6,69327250-3,5957,5001,910-4,142236-1,290351,2931,05300000000
Inventory -3,480-3,8101,130-6,6795251,968793650-2,730-1,832-1,689-1,1591,047-2,4801,813-2047561,785-2,515-1,055
Accounts Payables 275513-3,8042,671890-54644-979-21500000000000
Other Working Capital 610-2,2302,540-83381-2,771-2,921-2,498-2,0432,4291,7012,591-4,789379-1,0164,396-1,450-2,5112,7771,024
Other Non Cash Items 10,602-18,968-18,820-5,480-2,554-3,943-3,216-4,197-2,943-6,599-3,657-2,527-1,921-2,35249320-1,333-1,717-3,917-6,397
Operating Cash Flow -1,677-6,6791,533-2,54213,9346,3468,8456,4415,7636,66711,9459,2875,0464,68810,69511,5796,3063,9583,0704,563
Investing Activities:
Investments In Property Plant And Equipment -3,089-2,547-1,919-1,485-1,302-1,333-2,120-2,532-2,281-2,365-2,108-1,883-1,976-2,011-2,290-1,211-2,861-5,279-3,088-3,569
Acquisitions Net 175-363-385-519-261-87-195-1,301-282-345-137-230146-104-364-34-1820-659-1,900
Purchases Of Investments -2,400-1,866-5,757-3,839-764-480-3,204-4,426-2,773-2,103-2,235-497-1,079-895-1,805-826-5,607-3,901-3,797-2,156
Sales Maturities Of Investments 11,90214,98522,2454,7272,9282812,7142,2027711,2352,051346513609855414,66804,6321,821
Other Investing Activites 2,104-4,208-3,408-8,213-111-468-154-1,246-1,705-326-222-294-44372-3021454319,449-41-2,556
Investing Cash Flow 8,6906,00110,776-9,329490-2,087-2,959-4,671-5,685-3,168-2,315-2,075-2,776-1,941-3,040-1,655-3,0541,594-1,570-4,549
Financing Activities:
Debt Repayment -283-150-103-16-1,934-30-150-85-185-201-476-221-714-439-814-12,712-830-1,756-2,246-505
Common Stock Issued 000-2040026417014613718390256011211,56032
Common Stock Repurchased -6,00000-1,30300-4,464-1,649-2-7,906-3-1-4,340-3-37-101-89-59-82-105
Dividends Paid -3,722-3,135-2,536-2,475-2,382-2,289-2,270-2,201-2,103-2,110-2,007-1,904-1,849-1,791-1,683-1,574-1,519-1,411-1,194-1,087
Other Financing Activities -1-135-117-2-10313-1169144136182882549629301,1911,980-8,0202,029940
Financing Cash Flow -10,006-3,420-2,756-4,000-4,419-2,306-6,621-3,766-2,146-10,081-2,304-2,038-6,649-1,271-1,603-13,184-1,447-11,246-1,490-1,225
Other Information:
Effect Of Forex Changes On Cash -3-214-1-11-2020460-1240-3-10-6032-12
Net Change In Cash -2,997-4,1209,557-15,87210,0041,955-738-1,996-2,048-6,1237,3145,178-4,3801,4726,068-3,2611,920-5,693664-1,188
Cash At End Of Period 45,88748,88453,00443,44759,31949,31547,36048,09850,09452,14258,26550,95145,77350,15348,68142,61345,87443,95449,64748,983